The Role of Genetic Factors in the Development of Arterial Hypertension in the Kazakh Population
Preventive and Personalized Medicine (2021-2023)
Sponsor: Asfendiyarov Kazakh National Medical University
This observational or N/A phase trial investigates Arterial Hypertension and is currently completed. Asfendiyarov Kazakh National Medical University leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2023 — Jul 2024 [monthly]
Completed
Status: Not Yet Recruiting → Completed
-
Dec 2021 — Apr 2023 [monthly]
Not Yet Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Asfendiyarov Kazakh National Medical University
For direct contact, visit the study record on ClinicalTrials.gov .